[Featured Stock] Theragen, Government Builds 1 Million Bio Big Data... 'Rising'

[Asia Economy Reporter Hyunseok Yoo] Theragen Etex is on the rise. It appears to be influenced by the government's announcement to promote the 'Construction of Bio Big Data for 1 Million People.'

As of 2:17 PM on the 26th, Theragen Etex was trading at 8,370 KRW, up 2.32% (190 KRW) compared to the previous trading day.

Hong Nam-ki, Deputy Prime Minister and Minister of Economy and Finance, stated at the '10th Innovation Growth BIG3 Promotion Meeting' held this morning, "To become one of the top 5 global countries in the precision medicine field, we will invest about 1 trillion KRW over six years starting in 2023 to build bio big data for 1 million citizens."

According to the meeting, the 'Bio Big Data for 1 Million People' project is currently conducting a pilot project worth 40 billion KRW this year, and the main project is planned to be promoted over the next six years with a budget of 987.8 billion KRW.

Theragen Etex's subsidiary, Theragen Bio, has been selected as the lead institution for this ongoing pilot project and is producing genomic data based on next-generation sequencing (NGS) technology.

Right after being selected as the pilot project operator in October last year, Theragen Bio stated, "We will concentrate all our capabilities to successfully lead the pilot project, lay the foundation for the main project, and contribute to establishing a high-quality national medical service infrastructure and securing competitiveness in the bio healthcare industry."

Theragen Bio is expanding its business based on genome analysis and gene-based prediction and diagnosis into areas such as personalized cancer vaccine development, bioinformatics data platforms, and AI-based new drug development.

This content was produced with the assistance of AI translation services.